Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
ClinicalTrials.gov study NCT00526643. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.
ClinicalTrials.gov study NCT00191620. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT04527679. IPD Sharing: NO. Countries: 1. Publications: 3.
Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer
ClinicalTrials.gov study NCT00960284. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors
ClinicalTrials.gov study NCT03237390. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT03401827. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00615446. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT03520790. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT02047513. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
ClinicalTrials.gov study NCT00006028. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
ClinicalTrials.gov study NCT01261728. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT05979298. IPD Sharing: NO. Countries: 1. Publications: 2.
Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT03636308. IPD Sharing: NO. Countries: 1. Publications: 2.
A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01028495. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00079287. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.
ClinicalTrials.gov study NCT04652206. IPD Sharing: NO. Countries: 2. Publications: 0.
Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00276588. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer
ClinicalTrials.gov study NCT00101907. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00079261. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01130142. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.